Research Keywords
- Rhinitis, Allergic, Perennial
- Pulmonary Disease, Chronic Obstructive
- GERD
- Cystic Fibrosis
- Asthma, Exercise-Induced
- Asthma Management
- Asthma
- Anti-Asthmatic Agents
Grants, Contracts & Research Gifts
- Comparative Effectiveness of Dual Bronchodilation for Treatment of Chronic Obstructive Pulmonary Disorder (COPD) in a Usual-Care Setting . PI: Asche Carl V. Co-PI(s): Young David, Yu Junhua, Ye Xiangyang, Oberg Brian. Novartis Pharmaceuticals , 04/09/2009 - 05/31/2010. Total project budget to date: $299,798.00
- Impact of individualized, pharmacist-provided asthma education in an Asthma Care Pharmacy . PI: David Young. Co-PI(s): Zobell J, Jorgensen R, Jennings B, Wagner D, Jolley T, Atherton A, Fitzpatrick R, Samuelson W. Marriner S Eccles Foundation, 03/31/2009 - present. Total project budget to date: $6,500.00
- COPD: Impact of Intervention on Compliance to the recommended HEDIS guidelines, Clinical Outcomes and Cost of Illness. PI: Asche C. Co-PI(s): Brixner D, Young D. Boehringer-Ingelheim , 06/01/2006 - present. Total project budget to date: $153,000.00
- Elucidation of Acid-Induced Pulmonary Inflammation. PI: Peterson K. Co-PI(s): Samuelson W, Go M, Young DC, Sturrock A, Kuwada S, Ryujin D. Tap Pharmaceutical Products Inc, 07/01/2005 - present. Total project budget to date: $111,345.00
Research Interests
Dr. Young is the clinical pharmacist at the University of Utah Adult Cystic Fibrosis and Asthma Centers. Dr. Young is a member of the Cystic Fibrosis Foundation (CFF) Clinical Research, and CFF Infection Research Initiative Review Committees. Dr. Young is the Director of the CFF Implementation of Outpatient Pharmacy Services and Co-director of the CFF Pharmacist Mentorship Programs. Dr. Young is a member of the National Association of Boards of Pharmacy Multistate Pharmacy Jurisprudence Examination (MPJE) Committee. Dr. Young is a member of the Division of Occupational & Professional Licensing Utah Physician and Surgeon Licensing Board. Dr. Young is the program coordinator for PGY-2 Internal Medicine Pharmacy Residency at the University of Utah Health. Dr. Young is actively engaged in research regarding improving care for patients with cystic fibrosis and asthma.
Languages
- English, fluent.
Publications
- David C. Young, Pharm.D.; Jeffery T. Zobell, Pharm.D.; Dustin Waters, Pharm.D.; Krow Ampofo, M.D.; Chris Stockmann, MSc; Catherine M.T. Sherwin, Ph.D.; Michael Spigarelli, M.D., Ph.D. Optimization of Anti-pseudomonal Antibiotics for CysticFibrosis Pulmonary Exacerbations: IV. Colistimethate sodium. Pediatric Pulmonol. 2012 (DOI: 10.1002/ppul.22664).
Published, 09/04/2012.
http://onlinelibrary.wiley.com/doi/10.1002/ppul.22... - Chris Stockmann, MSc; Catherine M.T. Sherwin, Ph.D.; Jeffery T. Zobell, Pharm.D.; David C. Young, Pharm.D.; Dustin Waters, Pharm.D.; Michael Spigarelli, M.D., Ph.D.; Krow Ampofo, M.D. Optimization of Anti-pseudomonal Antibiotics for CysticFibrosis Pulmonary Exacerbations: III. Fluoroquinolones. Pediatric Pulmonol. 2012 (DOI: 10.1002/ppul.22667).
Published, 09/04/2012.
http://onlinelibrary.wiley.com/doi/10.1002/ppul.22... - Jeffery T. Zobell, Pharm.D.; Dustin Waters, Pharm.D.; David C. Young, Pharm.D.; Chris Stockmann, MSc; Krow Ampofo, M.D.; Catherine M.T. Sherwin, Ph.D.; Michael Spigarelli, M.D., Ph.D. Optimization of Anti-pseudomonal Antibiotics for CysticFibrosis Pulmonary Exacerbations: II. Penicillins and Cephalosporins. Pediatric Pulmonol. 2012 (DOI: 10.1002/ppul.22669).
Published, 09/04/2012.
http://onlinelibrary.wiley.com/doi/10.1002/ppul.22... - Jeffery T. Zobell, Pharm.D.; Dustin Waters, Pharm.D.; David C. Young, Pharm.D.; Chris Stockmann, MSc; Krow Ampofo, M.D.; Catherine M.T. Sherwin, Ph.D.; Michael Spigarelli, M.D., Ph.D. Optimization of Anti-pseudomonal Antibiotics for CysticFibrosis Pulmonary Exacerbations: I. Aztreonam and Carbapenems. Pediatric Pulmonol. 2012 (DOI: 10.1002/ppul.22655).
Published, 08/21/2012.
http://onlinelibrary.wiley.com/doi/10.1002/ppul.22... - 1. Carl Victor Asche, Shelah Leader, Craig Plauschinat, Ming Yan, Xiangyang Ye, David C. Young. Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids. International Journal of COPD 2012;7:201-209.
Published, 03/14/2012.
http://www.dovepress.com/articles.php?article_id=9... - David C. Young, Pharm.D. Maximizing Benefit/Minimizing Risk: PK-PD Considerations of Antipseudomonal Antibiotics. Pediatr Pulmonol 2011 Oct; Suppl 34: 155. Published, 11/03/2011.
- Jeffery T. Zobell, Pharm.D., Chris Stockmann, Ph.D.; Krow Ampofo, MD; David C. Young, Pharm.D.; Jared Cash, Pharm.D., BCPS; Brittany J. McDowell, Kent Korgenski, MS,MT(ACSP); Barbara A. Chatfield, MD. Pharmacodynamic Modeling of High Dose Intermittent Ticarcillin-clavulanate Administration In Pediatric Cystic Fibrosis Patients. Clinical Therapeutics 2011 Jul;9(4):280-3.
Published, 10/21/2011.
http://dx.doi.org/10.1016/j.clinthera.2011.09.010 - Jeffery T. Zobell, Pharm.D., David C. Young, Pharm.D., C. Dustin Waters, Pharm.D., BCPS, Krow Ampofo, M.D., Jared Cash, Pharm.D., BCPS, Bruce C. Marshall, M.D., Jared Olson, Pharm.D., and Barbara A. Chatfield, M.D. A Survey of the Utilization of Anti-Pseudomonal Beta-Lactam Therapy in Cystic Fibrosis Patients. Pediatric Pulmonology 2011;46:987-990.
Published, 04/25/2011.
http://onlinelibrary.wiley.com/doi/10.1002/ppul.21... - High dose intermittent ticarcillin–clavulanate administration in pediatric cystic fibrosis patients Jeffery T. Zobell, Krow Ampofo, Jared Cash, Kent Korgenski, Barbara A. Chatfield (Acknowledgements Young DC) Journal of Cystic Fibrosis - July 2010; Vol. 9, Issue 4, Pages 280-283. Published, 07/01/2010.
- The role of gastroesophageal reflux in exercise-triggered asthma: a randomized controlled trial. Peterson KA, Samuelson WM, Ryujin DT, Young DC, Thomas KL, Hilden K, Fang JC. Dig Dis Sci. 2009 Mar;54(3):564-71. Epub 2008 Aug 8. PMID: 18688720 [PubMed - indexed for MEDLINE].
Published, 03/01/2009.
http://www.ncbi.nlm.nih.gov/pubmed/18688720